8-oxo-dG Elevated in Children During Leukemia Treatment

Abstract

Changes in oxidative stress in children undergoing chemotherapy for acute lymphoblastic leukemia (ALL) have not been well documented. To determine whether the measurement of the DNA oxidized base 8-oxodeoxyguanosine (8-oxo-dG) may be a useful biomarker in this population, the authors conducted an observational study on 103 children with ALL. Blood samples were collected at diagnosis, during interim maintenance (IM), and during delayed intensification (DI). Blood mononuclear cell 8-oxo-dG, measured with an immunohistochemical method, decreased from diagnosis to IM ( P = .01) and increased between IM and DI ( P < .01). In a pilot study, bone marrow was also collected from 16 patients at diagnosis and after 28 days of treatment, but 8-oxo-dG remained the same. The relationship between plasma and dietary intake of antioxidants and the level of 8-oxo-dG was also explored. There was a direct relationship between the intake of vitamin E at diagnosis and bone marrow 8-oxo-dG ( P = .03) and an inverse relationship between β-carotene intake and blood 8-oxo-dG at IM ( P = .03) and vitamin A in-take and blood 8-oxo-dG at DI ( P = .003). Plasma vitamin C ( P = .02) and total carotenoids ( P = .01) were inversely related to blood 8-oxo-dG at IM. In contrast, higher plasma E/total lipid levels were associated with higher 8-oxo-dG at IM and DI ( P < .01). At IM, patients with higher 8-oxo-dG had an increased risk of chemotherapy dose reduction ( P = .04). In conclusion, the level of 8-oxo-dG in blood mononuclear cells decreases after the start of chemotherapy and increases during aggressive chemotherapy in children with ALL.

Keywords

8-oxo-dG acute lymphoblastic leukemia antioxidant chemotherapy toxicity nutrition bone marrow

References

1. Olinski R , Zastawny T , Budzbon J , et al. DNA base modification in chromatin of human cancerous tissues. FEBS Lett. 1992;309:193-198.

2. Halliwell B . Can oxidative DNA damage be used as a biomarker of cancer risk in humans? Problems, resolutions and preliminary results from nutritional supplementation studies. Free Radic Res. 1998;29:469-486.

3. Malins D , Haimanot R . Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 1991;51:5430-5432.

4. Malins D , Holmes E , Polissar N , Gunselman S . The etiology of breast cancer. Cancer. 1993;71:3036-3043.

5. Okamoto K , Toyokuni S , Uchida K , et al. Formation of 8-hydroxy-2-deoxyguanosineand 4-hydroxy-2-nonenal modified proteins in human renal-cell carcinoma. Int J Cancer. 1994;58:825-829.

6. Collins A , Gedik C , Olmedilla B , Southon S , Bellizzi M . Oxidative DNA damage measured in human lymphocytes: large differences between sexes and between countries, and correlations with heart disease mortality rates. FASEB J. 1998;12:1397-1400.

7. Vulimiri S , Wu X , Baer-Dubowska W , et al. Analysis of aromatic DNA adducts and 7, k8-dihydro-8-oxo-2-deoxyguanosine in lymphocyte DNA from a case-control study of lung cancer involving minority populations. Mol Carcinog. 2000;27:34-46.

8. Yamamoto T , Hosokawa K , Tamura T , Kanno H , Urabe M , Honjo H . Urinary 8-hydroxy-2-deoxyguanosine (8-OHdG) levels in women with or without gynecologic cancer. J Obstet Gynaecol Res. 1996;22:359-363.

9. Calderon-Garciduenas L , Wen-Wang L , Zhang R , et al. 8-hydroxy-2-deoxyguanosine, a major mutagenic oxidative DNA lesion, and DNA strand breaks in nasal respiratory epithelium of children exposed to urban pollution. Environ Health Perspect. 1999;107:469-474.

10.

10. Yarborough A , Zhang Y , Hsu T , Santella R . Immunoperoxidase detection of 8-hydroxydeoxyguanosine in aflatoxin B1-treated rat liver and human oral mucosal cells. Cancer Res. 1996;56:683-688.

11.

11. Jacobson J , Begg M , Wang L , et al. Effects of a 6-month vitamin intervention on DNA damage in healthy smokers. Cancer Epidemiol Biomarkers Prev. 2000;9:1303-1311.

12.

12. Bialkowski K , Kowara R , Windorbska W , Olinski R . 8-oxo-2-deoxyguanosine level in lymphocytes DNA of cancer patients undergoing radiotherapy. Cancer Lett. 1996;99:93-97.

13.

13. Zwingmann I , Welle I , Engelsen J , et al. Analysis of oxidative DNA damage and HPRT mutant frequencies in cancer patients before and after radiotherapy. Mutat Res. 1999;431:361-369.

14.

14. Doroshow J , Synold T , Somlo G , Akman S , Gajewski E . Oxidative DNA base modifications in peripheral blood mononuclear cells of patients treated with high-dose infusional doxorubicin. Blood. 2001;97:2839-2845.

15.

15. Faure H , Mousseau M , Cadet J , et al. Urine 8-oxo-7,8-dihydroguanosine vs 5-hydroxymethyl uracil as DNA oxidation marker in adriamycin-treated patients. Free Radic Res. 1998;28:377-382.

16.

16. Tagesson C , Kallberg M , Klintenberg C , Starkhammer H . Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage for cancer patients. Eur J Cancer. 1995;31A:934-940.

17.

17. Erhola M , Toyokuni S , Okada K , et al. Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett. 1997;409:287-291.

18.

18. Verhagen H , Poulsen H , Loft S , et al. Reduction of oxidative DNA-damage in humans by brussels sprouts. Carcinogenesis. 1995;16:969-970.

19.

19. Fraga C , Motchnik P , Shigenaga M , et al. Ascorbic acid protects against endogenous oxidative DNA damage in human sperm. Proc Natl Acad Sci U S A. 1991;88:11003-11006.

20.

20. van Poppel G , Poulsen H , Loft S , Verhagen H . No influence of beta carotene on oxidative DNA damage in male smokers. J Natl Cancer Inst. 1995;87:310-311.

21.

21. Prieme H , Loft S , Nyyssonen KJ , Poulsen H . No effect of supplementation with vitamin E, ascorbic acid, or coenzyme Q10 on oxidative DNA damage estimated by 8-oxo-7,8-dihydro-2-deoxyguanosine excretion in smokers. Am J Clin Nutr. 1997;65:503-507.

22.

22. Senturker S , Karahalil B , Inal M , et al. Oxidative DNA base damage and antioxidant enzyme levels in childhood acute lymphoblastic leukemia. FEBS Lett. 1997;416:286-290.

23.

23. Hu Z , Yang G , Miyamoto N , Minden M , McCulloch E . Mechanism of cytosine araninoside toxicity to the blast cells of acute myeloblastic leukemia: involvement of free radicals. Leukemia. 1995;9:789-798.

24.

24. Gressier B , Lebegue S , Brunet C , Luyckx M , Cazin M , Cazin J . Pro-oxidant properties of methotrexate: evaluation and prevention by an anti-oxidant drug. Pharmazie. 1994;49:679-681.

25.

25. Rockett H , Bretenbach M , Frazier A , et al. Validation of a youth/adolescent food frequency questionnaire. Prev Med. 1997;26:808-816.

26.

26. Behrens W , Madere R . A highly sensitive high-performance liquid chromatography method for the estimation of ascorbic and dehydroascorbic acid in tissues, biological fluids and foods. Anal Biochem. 1987;165:102-107.

27.

27. Bieri J , Tolliver T , Catignani G . Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high-pressure liquid chromatography. Am J Clin Nutr. 1979;32:2143-2149.

28.

28. Roels O , Trout M , Lui N , Anderson O . Vitamins and hormones: vitamin A and carotene. In: Standard Methods of Clinical Chemistry. New York, NY: Academic Press; 1972.

29.

29. Lopes-Virella M , Stone P , Ellis S , Colwell J . Cholesterol determination in high-density lipoprotein separated by three different methods. Clin Chem. 1997;23:882-884.

30.

30. Friedewald W , Levy R , Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.

31.

31. Yin B , Whyatt R , Perera F , Randall R , Cooper T . Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody based ELISA. Free Radic Biol Med. 1995;18:1023-1032.